Template forms
This page contains a list of template forms to assist you in conducting clinical trials.
Last updated 24 March 2026
Overview
The following list of template forms have been compiled from best practices noted from Good Clinical Practice Inspections conducted to date.
You may also choose not to use these templates if you have suitable alternatives available.
Disclaimer
These template forms are issued by HSA solely for the purpose of facilitating the conduct of your clinical trial. If necessary, customise these template forms to suit the needs of your clinical trial.
These template forms are provided on an "as is basis" for use at your own risk and without warranties of any kind. To the fullest extent permitted by law, HSA does not warrant and hereby disclaims all express, implied and statutory warranties of any kind to you or any third party whether arising from usage, custom, trade or by operation of law or otherwise, including but not limited to the following:
Any representations or warranties as to the accuracy, correctness, reliability, timeliness, non-infringement, title, merchantability or fitness for any particular purpose of the template forms; and
Any representations or warranties that the template forms will be error-free or that errors will be corrected.
HSA will not be liable to you or any third party for any loss or damage whatsoever including but not limited to direct, indirect, punitive, special or consequential damages, loss of income, revenue or profits, lost or damaged data, or damage to your computer, software, modem, telephone or other property, arising directly or indirectly from either of the following:
Accessing or using the template forms
Relying on any statements, opinions, representations or information in the template forms
Any decision, conduct or the views of any person taken in reliance on the contents of the template forms
It remains the responsibility of the sponsor and investigator to implement and maintain quality assurance and quality control systems to ensure that clinical trials are conducted in compliance with the protocol, standard operating procedures, Good Clinical Practice and applicable regulatory requirements.
HSA will not be in a position to review sponsor and site SOPs. In the event if you have any clarifications on the template forms, please submit an enquiry to HSA_CT@hsa.gov.sg.
References Used
Templates
List of templates
S/N | Category | Template Form | Purpose of Template Form |
|---|---|---|---|
1 | Protocol | Document the investigator's agreement to read and comply with the protocol and its amendments. | |
2 | Participants | Track the identity of the participants enrolled in the clinical trial. | |
Track the screening and enrollment of participants for the clinical trial. | |||
Track the scheduled and actual trial visits of the participants enrolled in the clinical trial to ensure that they comply with the trial visit schedule described in the protocol. | |||
3 | Investigator Site Staff | Document the persons or parties to whom the Principal Investigator (PI) has delegated trial-related activities. | |
Document the training received by the investigator site staff, in order to ensure they are appropriately qualified to conduct their delegated tasks in accordance with the Delegation Log.. | |||
4 | Submissions | Ensure that the required IRB and HSA approvals are sought prior to the implementation of essential records, where applicable. | |
5 | Informed Consent | Ensure that informed consent has been obtained from the participants or their legal representatives prior to trial participation, and that reconsent has been obtained from the participants, where applicable. | |
6 | Investigational Product (IP) management | Provide written instructions on the handling and storage of Investigational Products (IP) used in this clinical trial. | |
Document the IP inventory at the investigator site, taking into account the quantity of IP received at the investigator site and dispensed to participants. | |||
Ensure that the IP is stored as specified by the sponsor and in accordance with applicable regulatory requirement(s). | |||
Document any temperature excursions noted during IP shipment or IP storage. | |||
Ensure that the IPs are manufactured, handled and labelled in a manner that aligns with the treatment assignment and maintains study blinding (where applicable). | |||
Document the transfer of the IP for the clinical trial. | |||
Document that the IP is used in accordance with the approved protocol. | |||
Document the return / destruction of the IP for the clinical trial. | |||
7 | Safety Reporting | Track the AEs reported for each participant for the clinical trial, as defined in the trial protocol. | |
Track the occurrence and notification of SAEs reported for the clinical trial, as defined in the trial protocol. | |||
8 | Deviations and Noncompliance | Document and track deviations and non-compliances for the clinical trial. | |
9 | Biological Samples | Document the location of the retained biological samples. | |
10 | Essential Records | Define what is considered to be a source record(s), the methods of data capture and their location prior to starting the trial. | |
Provide guidance on the essential records to be maintained by the investigator. |